- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | First Faculty of Medicine, Second Faculty of Medicine
- Current treatment of non-metastatic castration-refractory prostate cancer2021 | First Faculty of Medicine
- Overview of serum markers of prostate cancer2023 | First Faculty of Medicine
- Prostate-specific antigen: Current status2001 | Third Faculty of Medicine
